Cambridge Investment Research Advisors »

Tarsus Pharmaceuticals shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $896k 25k 36.35
2023-12-31 $424k 21k 20.24
2023-09-30 $369k 21k 17.78

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corp Com (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Value Etf (VTV)

View all positions for Cambridge Investment Research Advisors

Top funds holding Tarsus Pharmaceuticals

Cormorant Asset Management
Tang Capital Management
Cowen And Company
Frazier Life Sciences Management
Vanguard Group
Jennison Associates
Perceptive Advisors
Paradigm Biocapital Advisors
Polygon Management
Ikarian Capital
Vivo Capital
Dimensional Fund Advisors
Artisan Partners Limited Partnership
Nantahala Capital Management
Bank of America Corporation

View all funds holding Tarsus Pharmaceuticals